Current status and challenges of drug development for hormonal treatment of endometriosis: a systematic review of randomized control trials

References

• Deiana D, Gessa S, Anardu M, et al. Genetics of endometriosis: a comprehensive review. Gynecol Endocrinol. 2019;35(7):553–558.
   PubMed Web of Science ®Google Scholar
• Murgia F, Angioni S, D’Alterio MN, et al. Metabolic profile of patients with severe endometriosis: a prospective experimental study. Reprod Sci. 2021;28(3):728–735.
   PubMed Web of Science ®Google Scholar
• D’Alterio MN, Giuliani C, Scicchitano F, et al. Possible role of microbiome in the pathogenesis of endometriosis. Minerva Obstet Gynecol. 2021;73(2):193–214.
   Google Scholar
• Stochino-Loi E, Darwish B, Mircea O, et al. Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis? Fertil Steril. 2017;107(3):707–713.e3.
   PubMed Web of Science ®Google Scholar
• Melis I, Agus M, Pluchino N, et al. Alexithymia in women with deep endometriosis? A pilot study. J Endometriosis Pelvic Pain Disord. 2014;6(1):26–33.
   Google Scholar
• Škegro B, Bjedov S, Mikuš M, et al. Endometriosis, pain and mental health. Psychiatr Danub. 2021;33(Suppl 4):632–636.
   PubMedGoogle Scholar
• Angioni S, Nappi L, Sorrentino F, et al. Laparoscopic treatment of deep endometriosis with a diode laser: our experience. Arch Gynecol Obstet. 2021;304(5):1221–1231.
   PubMed Web of Science ®Google Scholar
• Angioni S, Cela V, Sedda F, et al. Focusing on surgery results in infertile patients with deep endometriosis. Gynecol Endocrinol. 2015;31(8):595–598.
   PubMed Web of Science ®Google Scholar
• Brichant G, Laraki I, Henry L, et al. New therapeutics in endometriosis: a review of hormonal, non-hormonal, and non-coding RNA treatments. Int J Mol Sci. 2021;22(19):10498.
   PubMed Web of Science ®Google Scholar
• Stochino-Loi E, Pontis A, Cofelice V, et al. Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: an open-label pilot study. Int J Womens Health. 2019;11:443–449. volume
   PubMed Web of Science ®Google Scholar
• Dunselman GaJ, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–412.
   PubMed Web of Science ®Google Scholar
• Acién P, Velasco I, Acién M. Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial. BMC Womens Health. 2021;21:211.
   PubMed Web of Science ®Google Scholar
• Almassinokiani F, Almasi A, Akbari P, et al. Effect of Letrozole on endometriosis-related pelvic pain. Med J Islam Repub Iran. 2014;28:107.
   PubMedGoogle Scholar
• Carbonell JL, Riverón AM, Leonard Y, et al. Mifepristone 2.5, 5, 10mg versus placebo in the treatment of endometriosis. J Reprod Health Med. 2016;2:17–25.
   Google Scholar
• Carr B, Dmowski WP, O’Brien C, et al. Elagolix, an Oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density. Reprod Sci. 2014;21:1341–1351.
   PubMed Web of Science ®Google Scholar
• D’Hooghe T, Fukaya T, Osuga Y, et al. Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study. Human Reprod. 2019;34:813–823.
   PubMed Web of Science ®Google Scholar
• Donnez J, Taylor HS, Taylor RN, et al. Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial. Fertil Steril. 2020;114:44–55.
   PubMed Web of Science ®Google Scholar
• Harada T, Osuga Y, Suzuki Y, et al. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study. Fertili Steril. 2022;117:583–592.
   PubMed Web of Science ®Google Scholar
• Osuga Y, Seki Y, Tanimoto M, et al. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose–response manner: a randomized, double-blind, placebo-controlled study. Fertil Steril. 2021;115:397–405.
   PubMed Web of Science ®Google Scholar
• Osuga Y, Seki Y, Tanimoto M, et al. Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results. BMC Women’s Health. 2021;21:250.
   PubMed Web of Science ®Google Scholar
• Surrey E, Taylor HS, Giudice L, et al. Long-term outcomes of elagolix in women with endometriosis: results from two extension studies. Obstet Gynecol. 2018;132:147–160.
   PubMed Web of Science ®Google Scholar
• Angioni S, Pontis A, Malune ME, et al. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol. 2020;36:84–86.
   PubMed Web of Science ®Google Scholar
• Angioni S, Cofelice V, Sedda F, et al. Progestins for symptomatic endometriosis: results of clinical studies. CDTH. 2015;10:91–104.
   Google Scholar
• The members of the Endometriosis Guideline Core Group, Becker CM, Bokor A, et al. ESHRE guideline: endometriosis. Human Reprod Open. 2022;2022:hoac009.
   PubMedGoogle Scholar
• Küpker W, Felberbaum R, Krapp M, et al. Use of GnRH antagonists in the treatment of endometriosis. Reprod BioMed Online. 2002;5:12–16.
   PubMedGoogle Scholar
• Melis GB, Neri M, Corda V, et al. Overview of elagolix for the treatment of endometriosis. Exp Opin Drug Metabol Toxicol. 2016;12:581–588.
   PubMed Web of Science ®Google Scholar
• Taylor HS, Giudice LC, Lessey BA, et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. N Engl J Med. 2017;377:28–40.
   PubMed Web of Science ®Google Scholar
• Alessandro P, Luigi N, Felice S, et al. Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature. Arch Gynecol Obstet. 2017;295:827–832.
   PubMed Web of Science ®Google Scholar
• Mori T, Ito F, Koshiba A, et al. Local estrogen formation and its regulation in endometriosis. Reprod Med Biol. 2019;18:305–311.
   PubMed Web of Science ®Google Scholar
• Słopień R, Męczekalski B. Aromatase inhibitors in the treatment of endometriosis. Prz Menopauzalny. 2016;15:43–47.
   PubMedGoogle Scholar
• Bedaiwy MA, Alfaraj S, Yong P, et al. New developments in the medical treatment of endometriosis. Fertil Steril. 2017;107:555–565.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Luan X, Wang Y. Letrozole combined with oral contraceptives versus oral contraceptives alone in the treatment of endometriosis-related pain symptoms: a pilot study. Gynecol Endocrinol. 2021;37:51–55.
   PubMed Web of Science ®Google Scholar
• Giarrè G, Franchini M, Castellacci E, et al. Ulipristal acetate in symptomatic uterine fibroids. A real-world experience in a multicentric Italian study. Gynecol Endocrinol. 2020;36:171–174.
   PubMed Web of Science ®Google Scholar
• Fu J, Song H, Zhou M, et al. Progesterone receptor modulators for endometriosis. Cochrane Database Syst Rev. 2017;7:CD009881.
   PubMedGoogle Scholar
• Tosti C, Biscione A, Morgante G, et al. Hormonal therapy for endometriosis: from molecular research to bedside. Eur J Obstet Gynecol Reprod Biol. 2017;209:61–66.
   PubMed Web of Science ®Google Scholar
• Zhang YX. Effect of mifepristone in the different treatments of endometriosis. Clin Exp Obstet Gynecol. 2016;43:350–353.
   PubMed Web of Science ®Google Scholar
• Y. Maximov P, M. Lee T, Craig Jordan V. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice. CCP. 2013;8:135–155.
   Google Scholar
• Lyu H, Liu Y, Dang Q, et al. [Effect of bazedoxifene on endometriosis in a rat model]. Zhonghua Fu Chan Ke Za Zhi. 2015;50:291–295.
   PubMedGoogle Scholar
• Yao Z, Shen X, Capodanno I, et al. Validation of rat endometriosis model by using raloxifene as a positive control for the evaluation of novel SERM compounds. J Invest Surg. 2005;18:177–183.
   PubMed Web of Science ®Google Scholar
• Stratton P, Sinaii N, Segars J, et al. Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet Gynecol. 2008;111:88–96.
   PubMed Web of Science ®Google Scholar
• Guo S-W, Groothuis PG. Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? Human Reprod Update. 2018;24:577–598.
   PubMed Web of Science ®Google Scholar